Uvax Bio

www.uvaxbio.com

100 Biddle Ave., Suite 202

Newark, DE 19702

Company Info

Year Established
2018

Contacts

Ji Li, PhD.
Co-Founder & CEO

Jiang Zhu, PhD.
Co-Founder & CSO

Mark Blomquist, MBA, JD., CFA
CFO

Kevin O'Neill
Senior VP, Corporate Strategy

Company Description

Uvax Bio employs proprietary 1c-SApNPᆴ platform technology to develop and commercialize prophylactic vaccines for the most challenging infectious diseases.